Validation of methylation markers for diagnosis of oral cavity cancer

European Journal of Cancer

Volumn 51, Issue 5, 2015, Pages 632-641

  Arantes, L M R B ^a,b   De Carvalho, A C ^b   Melendez, M E ^b   Centrone, C C ^c   Gois Filho J F ^d   Toporcov, T N ^c   Caly, D N ^e   Tajara, E H ^a   Goloni Bertollo, E M ^a   Carvalho, A L ^b  

^a FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

^b BARRETOS CANCER HOSPITAL   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d Instituto do Cancer Dr Arnaldo   (Brazil)

^e HOSPITAL HELIÓPOLIS   (Brazil)

Author keywords

CCNA1; DAPK; DCC; Methylation markers; OSCC; TIMP3

Indexed keywords

TUMOR MARKER; CCNA1 PROTEIN, HUMAN; CELL SURFACE RECEPTOR; CYCLIN A1; DCC PROTEIN, HUMAN; DEATH ASSOCIATED PROTEIN KINASE; TIMP3 PROTEIN, HUMAN; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA METHYLATION; FEMALE; GENE IDENTIFICATION; GENETIC ASSOCIATION; HUMAN; MALE; MIDDLE AGED; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; BRAZIL; CASE CONTROL STUDY; CLINICAL TRIAL; FEASIBILITY STUDY; GENETIC EPIGENESIS; GENETIC SCREENING; GENETICS; HEAD AND NECK TUMOR; MOUTH TUMOR; MULTICENTER STUDY; PREDICTIVE VALUE; PROCEDURES; REPRODUCIBILITY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; BRAZIL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CYCLIN A1; DEATH-ASSOCIATED PROTEIN KINASES; DNA METHYLATION; EPIGENESIS, GENETIC; FEASIBILITY STUDIES; FEMALE; GENETIC TESTING; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROMOTER REGIONS, GENETIC; RECEPTORS, CELL SURFACE; REPRODUCIBILITY OF RESULTS; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 84924386476     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2015.01.060     Document Type: Article

References (39)

1. L. Kim, T. King, and M. Agulnik Head and neck cancer: changing epidemiology and public health implications Oncology 24 10 2010 915 919 924
2. L.G. Marcu, and E. Yeoh A review of risk factors and genetic alterations in head and neck carcinogenesis and implications for current and future approaches to treatment J Cancer Res Clin Oncol 135 10 2009 1303 1314
3. C.C. Ragin, F. Modugno, and S.M. Gollin The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus J Dent Res 86 2 2007 104 114
4. Q. Wang, P. Gao, X. Wang, and Y. Duan Investigation and identification of potential biomarkers in human saliva for the early diagnosis of oral squamous cell carcinoma Clin Chim Acta 427 2014 79 85
5. L. Montebugnoli, D.B. Gissi, F. Flamminio, L. Gentile, V. Dallera, and E. Leonardi et al. Clinicopathologic parameters related to recurrence and locoregional metastasis in 180 oral squamous cell carcinomas Int J Surg Pathol 22 1 2014 55 62
6. A. Grobe, M. Blessmann, H. Hanken, R.E. Friedrich, G. Schon, and J. Wikner et al. Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavity Clin Cancer Res 20 2 2014 425 433
7. C.R. Leemans, B.J. Braakhuis, and R.H. Brakenhoff The molecular biology of head and neck cancer Nat Rev Cancer 11 1 2011 9 22
8. E.H. Olivieri, S.D. da Silva, F.F. Mendonca, Y.N. Urata, D.O. Vidal, and A. Faria Mde CYP1A2∗1C, CYP2E1∗5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients Oral Oncol 45 9 2009 e73 e79
9. S. Markopoulou, G. Nikolaidis, and T. Liloglou DNA methylation biomarkers in biological fluids for early detection of respiratory tract cancer Clin Chem Lab Med 50 10 2012 1723 1731
10. S. Leng, Y. Liu, C.L. Thomas, W.J. Gauderman, M.A. Picchi, and S.E. Bruse et al. Native American ancestry affects the risk for gene methylation in the lungs of Hispanic smokers from New Mexico Am J Respir Crit Care Med 188 9 2013 1110 1116
11. R. Garcia-Baquero, P. Puerta, M. Beltran, M. Alvarez, R. Sacristan, and J.L. Alvarez-Ossorio et al. Methylation of a novel panel of tumor suppressor genes in urine moves forward noninvasive diagnosis and prognosis of bladder cancer: a 2-center prospective study J Urol 190 2 2013 723 730
12. T.C. Zuiverloon, W. Beukers, K.A. van der Keur, A.J. Nieuweboer, T. Reinert, and L. Dyrskjot et al. Combinations of urinary biomarkers for surveillance of patients with incident nonmuscle invasive bladder cancer: the European FP7 UROMOL project J Urol 189 5 2013 1945 1951
13. A.M. Matthews, H. Kaur, M. Dodd, J. D'Souza, T. Liloglou, and R.J. Shaw et al. Saliva collection methods for DNA biomarker analysis in oral cancer patients Br J Oral Maxillofac Surg 51 5 2013 394 398
14. M.M. Rettori, A.C. de Carvalho, A.L. Bomfim Longo, C.Z. de Oliveira, L.P. Kowalski, and A.L. Carvalho et al. Prognostic significance of TIMP3 hypermethylation in post-treatment salivary rinse from head and neck squamous cell carcinoma patients Carcinogenesis 34 1 2013 20 27
15. W. Sun, D. Zaboli, Y. Liu, D. Arnaoutakis, T. Khan, and H. Wang et al. Comparison of promoter hypermethylation pattern in salivary rinses collected with and without an exfoliating brush from patients with HNSCC PLoS One 7 3 2012 e33642
16. A.L. Carvalho, R. Henrique, C. Jeronimo, C.S. Nayak, A.N. Reddy, and M.O. Hoque et al. Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance Clin Cancer Res 17 14 2011 4782 4789
17. D. Twelves, A. Nerurkar, P. Osin, T. Dexter, A. Ward, and G.P. Gui et al. DNA promoter hypermethylation profiles in breast duct fluid Breast Cancer Res Treat 139 2 2013 341 350
18. T. Muraoka, J. Soh, S. Toyooka, K. Aoe, N. Fujimoto, and S. Hashida et al. The degree of microRNA-34b/c methylation in serum-circulating DNA is associated with malignant pleural mesothelioma Lung Cancer 82 3 2013 485 490
19. Z.H. Zhao, Y.C. Fan, Y. Yang, and K. Wang Association between Ras association domain family 1A promoter methylation and hepatocellular carcinoma: a meta-analysis World J Gastroenterol 19 41 2013 7189 7196
20. Y.T. Huang, F.F. Li, C. Ke, Z. Li, Z.T. Li, and X.F. Zou et al. PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy J Transl Med 11 2013 245
21. S.L. Rosas, W. Koch, M.G. da Costa Carvalho, L. Wu, J. Califano, and W. Westra et al. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients Cancer Res 61 3 2001 939 942
22. C.A. Righini, F. de Fraipont, J.F. Timsit, C. Faure, E. Brambilla, and E. Reyt et al. Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence Clin Cancer Res 13 4 2007 1179 1185
23. A.L. Carvalho, C. Jeronimo, M.M. Kim, R. Henrique, Z. Zhang, and M.O. Hoque et al. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma Clin Cancer Res 14 1 2008 97 107
24. L.M. Arantes, A.C. de Carvalho, M.E. Melendez, A.L. Carvalho, and E.M. Goloni-Bertollo Methylation as a biomarker for head and neck cancer Oral Oncol 50 6 2014 587 592
25. O. Brinkmann, D.A. Kastratovic, M.V. Dimitrijevic, V.S. Konstantinovic, D.B. Jelovac, and J. Antic et al. Oral squamous cell carcinoma detection by salivary biomarkers in a Serbian population Oral Oncol 47 1 2011 51 55
26. N.J. Park, H. Zhou, D. Elashoff, B.S. Henson, D.A. Kastratovic, and E. Abemayor et al. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection Clin Cancer Res 15 17 2009 5473 5477
27. Y. Li, X. Zhou, M.A. St John, and D.T. Wong RNA profiling of cell-free saliva using microarray technology J Dent Res 83 3 2004 199 203
28. S. Pierini, S.H. Jordanov, A.V. Mitkova, I.J. Chalakov, M.B. Melnicharov, and K.V. Kunev et al. Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients Head Neck 36 8 2013 1103 1108
29. R.J. Shaw, G.L. Hall, D. Lowe, N.L. Bowers, T. Liloglou, and J.K. Field et al. CpG island methylation phenotype (CIMP) in oral cancer: associated with a marked inflammatory response and less aggressive tumour biology Oral Oncol 43 9 2007 878 886
30. R.P. Dikshit, A. Gillio-Tos, P. Brennan, L. De Marco, V. Fiano, and J.M. Martinez-Penuela et al. Hypermethylation, risk factors, clinical characteristics, and survival in 235 patients with laryngeal and hypopharyngeal cancers Cancer 110 8 2007 1745 1751
31. K. Kato, A. Hara, T. Kuno, H. Mori, T. Yamashita, and M. Toida et al. Aberrant promoter hypermethylation of p16 and MGMT genes in oral squamous cell carcinomas and the surrounding normal mucosa J Cancer Res Clin Oncol 132 11 2006 735 743
32. C. Zuo, L. Ai, P. Ratliff, J.Y. Suen, E. Hanna, and T.P. Brent et al. O6-methylguanine-DNA methyltransferase gene: epigenetic silencing and prognostic value in head and neck squamous cell carcinoma Cancer Epidemiol Biomarkers Prev 13 6 2004 967 975
33. S. Demokan, A. Chuang, Y. Suoglu, M. Ulusan, Z. Yalniz, and J.A. Califano et al. Promoter methylation and loss of p16(INK4a) gene expression in head and neck cancer Head Neck 34 10 2012 1470 1475
34. M. Hasegawa, H.H. Nelson, E. Peters, E. Ringstrom, M. Posner, and K.T. Kelsey Patterns of gene promoter methylation in squamous cell cancer of the head and neck Oncogene 21 27 2002 4231 4236
35. M. Brait, M. Loyo, E. Rosenbaum, K.L. Ostrow, A. Markova, and S. Papagerakis et al. Correlation between BRAF mutation and promoter methylation of TIMP3, RARbeta2 and RASSF1A in thyroid cancer Epigenetics 7 7 2012 710 719
36. C.J. Marsit, M.R. Posner, M.D. McClean, and K.T. Kelsey Hypermethylation of E-cadherin is an independent predictor of improved survival in head and neck squamous cell carcinoma Cancer 113 7 2008 1566 1571
37. R.V. de Moraes, D.T. Oliveira, G. Landman, F. de Carvalho, O. Caballero, and S. Nonogaki et al. E-cadherin abnormalities resulting from CPG methylation promoter in metastatic and nonmetastatic oral cancer Head Neck 30 1 2008 85 92
38. R.J. Shaw, T. Liloglou, S.N. Rogers, J.S. Brown, E.D. Vaughan, and D. Lowe et al. Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing Br J Cancer 94 4 2006 561 568
39. C. Sweeney, K.M. Boucher, W.S. Samowitz, R.K. Wolff, H. Albertsen, and K. Curtin et al. Oncogenetic tree model of somatic mutations and DNA methylation in colon tumors Genes Chromosomes Cancer 48 1 2009 1 9